Similar articles for PMID: 29218610

Year	Number of Results
2005	2
2006	1
2007	4
2008	9
2009	8
2010	9
2011	11
2012	9
2013	15
2014	16
2015	15
2016	14
2017	21
2018	18
2019	20
2020	25
2021	30
2022	22
2023	12
2024	0

1

Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study.

Han SN, Amant F, Michielsen K, De Keyzer F, Fieuws S, Van Calsteren K, Dresen RC, Gziri MM, Vandecaveye V. Han SN, et al. Eur Radiol. 2018 May;28(5):1862-1874. doi: 10.1007/s00330-017-5126-z. Epub 2017 Dec 7. Eur Radiol. 2018. PMID: 29218610

2

Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study.

De Vuysere S, Vandecaveye V, De Bruecker Y, Carton S, Vermeiren K, Tollens T, De Keyzer F, Dresen RC. De Vuysere S, et al. BMC Med Imaging. 2021 Feb 5;21(1):18. doi: 10.1186/s12880-021-00550-2. BMC Med Imaging. 2021. PMID: 33546626 Free PMC article.

3

Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.

Michielsen K, Vergote I, Op de Beeck K, Amant F, Leunen K, Moerman P, Deroose C, Souverijns G, Dymarkowski S, De Keyzer F, Vandecaveye V. Michielsen K, et al. Eur Radiol. 2014 Apr;24(4):889-901. doi: 10.1007/s00330-013-3083-8. Epub 2013 Dec 11. Eur Radiol. 2014. PMID: 24322510 Clinical Trial.

4

Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.

Johnston EW, Latifoltojar A, Sidhu HS, Ramachandran N, Sokolska M, Bainbridge A, Moore C, Ahmed HU, Punwani S. Johnston EW, et al. Eur Radiol. 2019 Jun;29(6):3159-3169. doi: 10.1007/s00330-018-5813-4. Epub 2018 Dec 5. Eur Radiol. 2019. PMID: 30519933 Free PMC article.

5

Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.

Li C, Liu ZS, Du XM, He L, Chen J, Wang W, Sun F, Du F, Luo ZG, Xue ZL, Zhao Y, Zhou CW. Li C, et al. Chin Med Sci J. 2009 Jun;24(2):112-6. doi: 10.1016/s1001-9294(09)60072-9. Chin Med Sci J. 2009. PMID: 19618609

6

18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.

Machado Medeiros T, Altmayer S, Watte G, Zanon M, Basso Dias A, Henz Concatto N, Hoefel Paes J, Mattiello R, de Souza Santos F, Mohammed TL, Verma N, Hochhegger B. Machado Medeiros T, et al. Eur Radiol. 2020 Jul;30(7):3641-3649. doi: 10.1007/s00330-020-06703-1. Epub 2020 Mar 3. Eur Radiol. 2020. PMID: 32125513

7

Accuracy of Whole-Body DWI for Metastases Screening in a Diverse Group of Malignancies: Comparison With Conventional Cross-Sectional Imaging and Nuclear Scintigraphy.

Paruthikunnan SM, Kadavigere R, Karegowda LH. Paruthikunnan SM, et al. AJR Am J Roentgenol. 2017 Sep;209(3):477-490. doi: 10.2214/AJR.17.17829. Epub 2017 Jul 5. AJR Am J Roentgenol. 2017. PMID: 28678578

8

Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study.

Spijkers S, Littooij AS, Kwee TC, Tolboom N, Beishuizen A, Bruin MCA, Elias SG, van de Brug T, Enríquez G, Sábado C, Miller E, Granata C, de Lange C, Verzegnassi F, Greer MC, de Keizer B, Nievelstein RAJ. Spijkers S, et al. Eur Radiol. 2021 Mar;31(3):1494-1504. doi: 10.1007/s00330-020-07182-0. Epub 2020 Sep 3. Eur Radiol. 2021. PMID: 32880696 Free PMC article.

9

Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients?

Petralia G, Padhani A, Summers P, Alessi S, Raimondi S, Testori A, Bellomi M. Petralia G, et al. Eur Radiol. 2013 Dec;23(12):3466-76. doi: 10.1007/s00330-013-2968-x. Epub 2013 Jul 25. Eur Radiol. 2013. PMID: 23884300 Clinical Trial.

10

Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer.

Michielsen K, Dresen R, Vanslembrouck R, De Keyzer F, Amant F, Mussen E, Leunen K, Berteloot P, Moerman P, Vergote I, Vandecaveye V. Michielsen K, et al. Eur J Cancer. 2017 Sep;83:88-98. doi: 10.1016/j.ejca.2017.06.010. Epub 2017 Jul 19. Eur J Cancer. 2017. PMID: 28734146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

213 results

Results by year